AelisFarma

The best
knowledge
in our field

AelisFarma

An international network
of partners

  • Neurocentre Magendie, INSERM, University of Bordeaux (France)

Aelis Farma first established its research and development on an exclusive collaboration with the Neurocentre Magendie  in Bordeaux,  one of the most respected and highly innovative Neuroscience Research centers in Europe with extensive experience in the CB1 receptor.

Recently, Aelis Farma extended its portfolio of international collaborations :

 

  • Universitat Pompeu Fabra (Barcelona, Spain)
    – Dr Rafael Maldonado
  • Columbia University (NY, USA)
    – Dr Margaret Haney
  • University of North Carolina Greensboro (USA)
    –Dr Patricia Reggio
  • University of Toronto (Canada)
    – Dr Ruth Ross
  • University of Aberdeen (Scotland, UK)
    – Dr Iain Greig

 

These extremely prestigious laboratories are complementary to Magendie for developing new signaling biased drugs. Thanks to this strategy, Aelis Farma has secured the most knowledge and expertise in the field of signaling specific drugs for the CB1 receptor and other similar GPCRs.

Logo01

 

Financial partners

In collaboration with Columbia University, Aelis Farma has been granted a 3.3 MUSD financing from  NIDA (National Institute on Drug Abuse)  in order to finance  the first  clinical studies for its lead compound AEF0117 in the treatment of cannabis abuse. To comply with specific NIH requirements, Aelis Farma has set up a FCOI (Financial Conflicts of Interest) policy which can be provided upon request at the following address: contact@aelisfarma.com.

fcoi-policy-aelis-farma

 

LogoFinancierShort

 

This internet site is co-financed by the European Union and the New Aquitaine Region.
L’Europe s’engage en Nouvelle Aquitaine avec les Fonds Européens de Développement Régional.

 

 

 

The best
knowledge
in our field

AelisFarma